Manulife (Manufacturers Life Insurance)
CRBP icon

Manulife (Manufacturers Life Insurance)’s Corbus Pharmaceuticals CRBP Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-22,924
Closed -$271K – 2910
2024
Q4 		$271K Buy
22,924
+193
+0.8% +$3.24K ﹤0.01% 2497
2024
Q3 		$469K Buy
22,731
+1,600
+8% +$81.9K ﹤0.01% 2319
2024
Q2 		$956K Buy
21,131
+10,604
+101% +$446K ﹤0.01% 1884
2024
Q1 		$413K Buy
+10,527
New +$260K ﹤0.01% 2273
2021
Q2 		– Sell
-1,676
Closed -$99K – 3231
2021
Q1 		$99K Buy
1,676
+396
+31% +$26K ﹤0.01% 3046
2020
Q4 		$48K Buy
1,280
+282
+28% +$10.5K ﹤0.01% 2975
2020
Q3 		$54K Sell
998
-297
-23% -$53.8K ﹤0.01% 2887
2020
Q2 		$307K Sell
1,295
-48
-4% -$9.7K ﹤0.01% 2235
2020
Q1 		$211K Buy
1,343
+152
+13% +$25.7K ﹤0.01% 2294
2019
Q4 		$195K Sell
1,191
-55
-4% -$8.13K ﹤0.01% 2613
2019
Q3 		$187K Hold
1,246
– – ﹤0.01% 2628
2019
Q2 		$259K Buy
1,246
+57
+5% +$12.2K ﹤0.01% 2461
2019
Q1 		$248K Buy
1,189
+90
+8% +$19.8K ﹤0.01% 2317
2018
Q4 		$192K Sell
1,099
-60
-5% -$12K ﹤0.01% 2338
2018
Q3 		$262K Sell
1,159
-226
-16% -$36.5K ﹤0.01% 2600
2018
Q2 		$210K Buy
1,385
+83
+6% +$15.1K ﹤0.01% 3095
2018
Q1 		$239K Buy
1,302
+32
+3% +$7.19K ﹤0.01% 2883
2017
Q4 		$270K Buy
1,270
+100
+9% +$21.4K ﹤0.01% 2786
2017
Q3 		$251K Sell
1,170
-36
-3% -$7.04K ﹤0.01% 2786
2017
Q2 		$228K Buy
+1,206
New +$236K ﹤0.01% 2900
2016
Q4 		– Sell
-83
Closed -$17K – 4354
2016
Q3 		$17K Buy
+83
New +$10.3K ﹤0.01% 3585

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EAM
Exome Asset Management New York $193M AUM 208.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s CRBP Position: Q1 2025 in Review

Manulife (Manufacturers Life Insurance) sold out of Corbus Pharmaceuticals (CRBP) in Q1 2025, closing a stake of 22,924 shares — an estimated $271K sold.

Manulife (Manufacturers Life Insurance) first reported a position in CRBP in Q3 2016 and held it in 21 quarters. The position peaked at $956K in Q2 2024. 86 funds tracked by Wall St. Rank hold CRBP as of Q1 2025.

  • Manulife (Manufacturers Life Insurance) reported no remaining Corbus Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 22,924 Corbus Pharmaceuticals shares in Q1 2025, an estimated $271K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Corbus Pharmaceuticals in Q3 2016 and held it in 21 quarters.
  • Manulife (Manufacturers Life Insurance)'s Corbus Pharmaceuticals position peaked at $956K in Q2 2024.
  • 86 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2025.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2025, filed 15 May 2025.